Synthesis and evaluation of in vitro bioactivity for polysubstituted N-arylpyrazole derivatives

Arabian Journal of Chemistry

Volumn 12, Issue 8, 2019, Pages 1908-1917

  Uramaru, Naoto ^a   Chang, En Chiuan ^b   Yen, Wan Ping ^c   Yeh, Mou Yung ^b   Juang, Shin Hun ^c,d   Wong, Fung Fuh ^c  

^a NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Benzothiophene; Bioactivity study; Pyrazole; Suzuki coupling reaction; Thiophene

Indexed keywords

CHEMICAL REACTIONS; T-CELLS; THIOPHENE;

1 ,3-DIPOLARCYCLOADDITION; BENZOTHIOPHENE; IN-VITRO BIOACTIVITY; INHIBITORY ACTIVITY; LUNG CARCINOMA; PYRAZOLES; SUZUKI COUPLING REACTION; T-CELL LEUKEMIA;

DISEASES;

EID: 85042783202     PISSN: 18785352     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arabjc.2014.12.004     Document Type: Article

References (47)

1. Ashalatha, B.V., Narayana, B., Vijaya, Raj.K.K.V., Kumari, N.S., Synthesis of some new bioactive 3-amino-2-mercapto-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one derivatives. Eur. J. Med. Chem. 5 (2007), 719–728.
2. Arroyo, S., Salas-Puig, J., Estudio abierto con tiagabina en epilepsia parcial. Rev. Neurol. 32 (2001), 1041–1046.
3. Bandgar, B.P., Totre, J.V., Gawande, S.S., Khobragade, C.N., Warangkar, S.C., Kadam, P.D., Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents. Bioorg. Med. Chem. 18 (2010), 6149–6155.
4. 3 adenosine receptors antagonists. J. Med. Chem. 46 (2003), 1229–1241.
5. 3 adenosine receptors in human tumor cell lines. Curr. Med. Chem. 12 (2005), 1319–1329.
6. Boschelli, D.H., Kramer, J.B., Connor, D.T., Lesch, M.E., Schrier, D.J., Ferin, M.A., Wright, C.D., 3-Alkoxybenzo[b]thiophene-2-carboxamides as inhibitors of neutrophil-endothelial cell adhesion. J. Med. Chem. 37 (1994), 717–718.
7. Boschelli, D.H., Kramer, J.B., Khatana, S.S., Sorenson, R.J., Connor, D.T., Ferin, M.A., Wright, C.D., Lesch, M.E., Imre, K., Okonkwo, G.C., Schrier, D.J., Conroy, M.C., Ferguson, E., Woelle, J., Saxena, U., Inhibition of E-Selectin-, ICAM-1-, and VCAM-1-mediated cell adhesion by benzo[b]thiophene-, benzofuran-, indole-, and naphthalene-2-carboxamides: identification of PD 144795 as an antiinflammatory agent. J. Med. Chem. 38 (1995), 4597–4614.
8. Butera, S.T., Roberts, B.D., Critchfield, J.W., Fang, G., Mcquade, T., Gracheck, S.J., Folks, T.M., Compounds that target novel cellular components involved in HIV-1 transcription. Mol. Med. 1 (1995), 758–767.
9. Carballo, M., Conde, M., Tejedo, J., Gualberto, A., Jimenez, J., Monteseirín, J., María, C.S., Bedoya, F.J., Hunt, S.W., Pintado, E., Baldwin, A.S. Jr., Sobrino, F., Macrophage inducible nitric oxide synthase gene expression is blocked by a benzothiophene derivative with anti-HIV properties. Mol. Genet. Metab. 75 (2002), 360–368.
10. Chang, E.-M., Chen, T.-H., Wong, F.F., Chang, E.-C., Yeh, M.-Y., Convenient and efficient synthesis of pyrazole-based DHODase inhibitors from 3-Aryl-4-cyanosydnone. Synlett 6 (2006), 901–904.
11. Chang, E.-M., Chen, T.-H., Wong, F.F., Chiang, K.-C., Yeh, M.-Y., Regioselectivity in 1,3-dipolar cycloaddition: reaction of 3-(p-Ethoxyphenyl)-4-cyanosydnone with propargylic esters. Heterocycles 68 (2006), 1007–1015.
12. Cheng, K.-M., Huang, Y.-Y., Huang, J.-J., Kaneko, K., Kimura, M., Takayama, H., Juang, S.-H., Wong, F.F., Synthesis and antiproliferative evaluation of N, N-disubstituted-N’-[1-aryl-1H-pyrazol-5-yl]-methnimidamides. Bioorg. Med. Chem. Lett. 20 (2010), 6781–6784.
13. Connor, D.T., Cetenko, W.A., Mullican, M.D., Sorenson, R.J., Unangst, P.C., Weikert, R.J., Adolphson, R.L., Dennedy, J.A., Thuseson, D.O., Wright, C.D., Conroy, M.C., Novel benzothiophene-, benzofuran-, and naphthalenecarboxamidotetrazoles as potential antiallergy agents. J. Med. Chem. 35 (1992), 958–965.
14. Critchfield, J.W., Coligan, J.E., Folks, T.M., Butera, S.T., Casein kinase II is a selective target of HIV-1 transcriptional inhibitors. Proc. Natl. Acad. Sci. U.S.A. 94 (1997), 6110–6115.
15. Dumitrascu, F., Mitan, C.I., Dumitrescu, D., Drãghici, C., Cãproiu, M.T., Steric effects on the sydnones reactivity. New sydnones and pyrazoles. ARKIVOC ii (2002), 80–86.
16. Foster, R.S., Jakobi, H., Harrity, J.P.A., Regioselectivity studies of sydnone cycloaddition reactions of azine-substituted alkynes. Tetrahedron Lett. 52 (2011), 1506–1508.
17. Foster, R.S., Jakobi, H., Harrity, J.P.A., A general and regioselective synthesis of 5-trifluoromethyl-pyrazoles. Org. Lett. 14 (2012), 4858–4861.
18. Fustero, S., Simon-Fuentes, A., Sanz-Cervera, J.F., Recent advances in the synthesis of pyrazoles. Org. Prep. Proc. Intl. 41 (2009), 253–290.
19. Huang, Y.-Y., Wang, L.-Y., Chang, C.-H., Kuo, Y.-H., Kaneko, M., Takayama, K., Kimura, H., Juang, S.-H., Wong, F.F., One-pot synthesis and antiproliferative evaluation of pyrazolo[3,4-d]pyrimidine derivatives. Tetrahedron 68 (2012), 9658–9664.
20. Kawashita, Y., Hayashi, M., Synthesis of heteroaromatic compounds by oxidative aromatization using an activated carbon/molecular oxygen system. Molecules 14 (2009), 3073–3093.
21. Lauria, A., Abbate, I., Patella, C., Gambino, N., Silvestri, A., Barone, G., Almerico, A.M., Pyrazolo[3,4-d][1,2,3]triazolo[1,5-a]pyrimidine: a new ring system through Dimroth rearrangement. Tetrahedron Lett. 49 (2008), 5125–5128.
22. Manns, M.P., McHutchison, J.G., Gordon, S.C., Rustgi, V.K., Mitchell, Shiffman, M., Reindollar, R., Goodman, Z.D., Koury, K., Ling, M.-H., Janice, K., Albrecht, J.K., Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. The Lancet 358 (2001), 958–965.
23. Miyaura, N., Suzuki, A., Palladium-catalyzed cross-coupling reactions of organoboron compounds. Chem. Rev. 95 (1995), 2457–2483.
24. Molvi, K.I., Vasu, K.K., Yerande, S.G., Sudarsanam, V., Haque, N., Syntheses of new tetrasubstituted thiophenes as novel anti-inflammatory agents. Eur. J. Med. Chem. 42 (2007), 1049–1058.
25. Noguchi, H., Kitazumi, K., Mori, M., Shiba, T., Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic in rats. J. Pharmacol. Sci. 94 (2004), 246–251.
26. Olah, E., Lui, M.S., Tseng, D.Y., Weber, G., Phase and cell cycle specificity of pyrazofurin action. Cancer Res. 40 (1980), 2869–2875.
27. Pastorin, G., Da Ros, T., Spalluto, G., Deflorian, F., Moro, S., Caccian, B., Baraldi, P.G., Gessi, S., Varani, K., Borea, P.A., Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors. J. Med. Chem. 46 (2003), 4287–4296.
28. Polivka, Z., Holubek, J., Svatek, E., Metys, J., Protiva, M., Potential hypnotics and anxiolytics: synthesis of 2-bromo-4-(2-chlorophenyl)-9-[4-(2-methoxyethyl)piperazino]-6H-thieno[3,2,4-triazolo[4,3-a]-1,4-diazepine and of some related compounds. Collect. Czech. Chem. Commun. 49 (1984), 621–636.
29. Puthiyapurayil, P., Poojary, B., Chikkanna, C., Buridipad, S.K., Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents. Eur. J. Med. Chem. 53 (2012), 203–210.
30. Qian, Y., Marugan, J.J., Fossum, R.D., Vogt, A., Sebti, S.M., Hamilton, A.D., Probing the hydrophobic pocket of farnesyltransferase: aromatic substitution of CAAX peptidomimetics leads to highly potent inhibitors. Bioorg. Med. Chem. 7 (1999), 3011–3024.
31. Rai, N.S., Kalluraya, B., Lingappa, B., Shenoy, S., Puranic, V.G., Convenient access to 1,3,4-trisubstituted pyrazoles carrying 5-nitrothiophene moiety via 1,3-dipolar cycloaddition of sydnones with acetylenic ketones and their antimicrobial evaluation. Eur. J. Med. Chem. 43 (2008), 1715–1720.
32. Roman, G., Mannich bases in medicinal chemistry and drug design. Eur. J. Med. Chem. 89 (2015), 743–816.
33. Romanelli, G.P., Autino, J.C., Recent applications of heteropolyacids and related compounds in heterocycles synthesis. Mini-Rev. Org. Chem. 6 (2009), 359–366.
34. Sagara, T., Okamura, M., Shimohigashi, Y., Ohno, M., Kanematsu, K., Specific affinity labeling of μ opioid receptors in rat brain by S-activated sulfhydryldihydromorphine analogs. Bioorg. Med. Chem. Lett. 5 (1995), 1609–1614.
35. Sangani, C.B., Makawana, J.A., Zhang, X., Teraiya, S.B., Lin, L., Zhu, H.-L., Design, synthesis and molecular modeling of pyrazole-quinoline-pyridine hybrids as a new class of antimicrobial and anticancer agents. Eur. J. Med. Chem. 53 (2014), 203–210.
36. Shia, C.S., Suresh, G., Hou, Y.C., Lin, Y.C., Chao, P.D., Juang, S.H., Suppression on metastasis by rhubarb through modulation on MMP-2 and uPA in human A549 lung adenocarcinoma: an ex vivo approach. J Ethnopharmacol. 133 (2011), 426–433.
37. Singh, P., Paul, K., Holzer, W., Synthesis of pyrazole-based hybrid molecules: search for potent multidrug resistance modulators. Bioorg. Med. Chem. 14 (2006), 5061–5071.
38. Sharma, S., Sharma, P.K., Kumar, N., Dudhe, R., A review on various heterocyclic moieties and their antitubercular activity. Biomed. Pharmacother. 65 (2011), 244–251.
39. 2A receptor antagonists: 2. reduction of hERG activity, observed species selectivity, and structure−activity relationships. J. Med. Chem. 51 (2008), 1730–1739.
40. Stauffer, S.R., Coletta, C.J., Tedesco, R., Nishigushi, G., Carlson, K.E., Sun, J., Katzenellenbogen, B.S., Katzenellenbogen, J.A., Pyrazole ligands: structure−affinity/activity relationships and estrogen receptor-α-selective agonists. J. Med. Chem. 43 (2000), 4934–4947.
41. Stauffer, S.R., Huang, Y.R., Aron, Z.D., Coletta, C.J., Sun, J., Katzenellenbogen, B.S., Katzenellenbogen, J.A., Triarylpyrazoles with basic side chains: development of pyrazole-based estrogen receptor antagonists. Bioorg. Med. Chem. 9 (2001), 151–161.
42. Sun, J., Lv, X.-H., Qiu, H.-Y., Wang, Y.-T., Du, Q.-R., Li, D.-D., Yang, Y.-H., Zhu, H.-Z., Synthesis, biological evaluation and molecular docking studies of pyrazole derivatives coupling with a thiourea moiety as novel CDKs inhibitors. Eur. J. Med. Chem. 68 (2013), 1–9.
43. Tu, S., Xie, Y.Q., Gui, S.Z., Ye, L.Y., Huang, Z.L., Huang, Y.B., Che, L.M., Synthesis and fungicidal activities of novel benzothiophene-substituted oxime ether strobilurins. Bioorg. Med. Chem. Lett. 24 (2014), 2173–2176.
44. Vidau, C., Brunet, J.-L., Badiou, A., Belzunces, L.P., Phenylpyrazole insecticides induce cytotoxicity by altering mechanisms involved in cellular energy supply in the human epithelial cell model Caco-2. Toxicol. In Vitro 23 (2009), 589–597.
45. Wang, H.W., Duffy, R.A., Boykow, G.C., Chackalamannil, S., Madison, V.S., Identification of novel cannabinoid CB1 receptor antagonists by using virtual screening with a pharmacophore model. J. Med. Chem. 51 (2008), 2439–2446.
46. Wen, K.-S., Lin, H.-Y., Huang, Y.-Y., Kaneko, K., Takayama, H., Kimura, M., Juang, S.-H., Wong, F.F., Chemoselective synthesis, antiproliferative activities and SAR study of 1H-pyrazol-5-yl-N, N-dimethylformamidines and pyrazolyl-2-azadienes. Med. Chem. Res. 21 (2012), 3920–3928.
47. Yeh, M.-Y., Tien, H.-J., Huang, L.-Y., Chen, M.-H., Sydnone compounds. XX. The synthesis and the Schmidt reaction of 4-formyl-3-arylsydnone. J. Chin. Chem. Soc. 30 (1983), 29–37.